Bed Bath & Beyond Inc. Common Stock (BBBY) fair value
Consumer Discretionary · Catalog/Specialty Distribution · NYSE · United States
$1.71+5.56%
Market cap $415MNext earnings 2026-08-04Updated Oct 16, 2026
Our verdict
Trades 51% below our fair value
Price
$1.71
Model fair valueConfidence: low
about $3.48
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Treated as a loss-making company. None of the usual models had enough data, so this uses Net asset value and Discounted cash flow instead.
ACCE opinionBed Bath & Beyond Inc. Common Stock (BBBY)
Fair value
Not available
ACCE price target
$1.40
Rating
Not rated
Horizon
12 months
ACCE price target published on 18 Oct 2026, 00:00 CEST.
Price used: $1.71 at the close on 15 Oct 2026, 22:00 CEST.
Models: Net asset value and Discounted cash flow.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
26
out of 100
P/E
0.0x
forward -54.8x
1-year return
-79.3%
Dividend yield
0.00%
Bed Bath & Beyond Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Bed Bath & Beyond Inc. (BBBY) is the post-bankruptcy shell of the former home goods retailer, and the company's operating business was sold off to Beyond Inc. (BYON) and other buyers, so what remains is a small residual entity rather than a conventional retailer. The data here shows a 0.0% revenue growth rate, zero reported ROE and operating margin, and a trailing P/E of 0.0 with a forward P/E of 12.9, which together point to no meaningful current earnings base to underwrite. The composite score of 26/100 and absence from any index reinforce that this does not screen as a high-quality business today. The only reason it merits a look is the possibility that the residual balance sheet or remaining claims carry value the headline metrics don't capture, and that question needs filings and a liquidation-style analysis before anything else.